Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |